相关实验视频
Updated: Jun 22, 2026

06:50
Extraction and Analysis of Taiwanese Green Propolis
Published on: January 7, 2019
关于绿茶提取物对抗肥胖的影响的综述
Hyeonji Lee1, Heeju Kim1, Sanguine Byun1
1Department of Biotechnology, Yonsei University, Seoul, 03722 Republic of Korea.
Food science and biotechnology
|March 28, 2025
概括
绿茶提取物在帮助减少身体脂肪和预防代谢障碍方面显示出对抗肥胖的前景. 本审查评估了其作为体重管理功能性食品的有效性和安全性.
科学领域:
- 营养药和功能性食品 营养药和功能性食品
- 代谢健康 代谢健康
- 肥胖问题研究研究
背景情况:
- 肥胖是一个全球性的健康危机,需要有效的管理策略.
- 饮食和运动至关重要,但通常很难维持.
- 需要新的治疗方法来应对肥胖流行病.
研究的目的:
- 评估绿茶提取物用于肥胖管理的治疗效果和安全性.
- 为了检查绿茶提取物对身体脂肪减少标记物的影响.
- 探索其在预防与肥胖相关的代谢障碍方面的潜力.
主要方法:
- 科学文献的系统审查.
- 对动物模型的分析和对绿茶提取物的人类研究.
- 评估肥胖指标:体重,BMI,身体脂肪百分比,腰围.
主要成果:
- 绿茶提取物在多项研究中证明有效降低身体脂肪标记物.
- 有证据表明,有潜力减轻与肥胖相关的代谢障碍.
- 评估了绿茶提取物用于肥胖管理的安全性.
结论:
- 绿茶提取物为肥胖管理提供了一种可行的营养药物选择.
- 进一步的研究支持其在控制体重的功能性食品中的作用.
- 它的疗效和安全性需要在治疗策略中考虑.
相关概念视频
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

